Wedo Venture Partners
Overview
Wedo Venture Partners is a venture capital firm that bridges science, culture, and capital from East and West to unlock human health, empowering the next generation of global biotech and medtech leaders.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Drug Farm | Jul 2026 | Series D | Co-investor |
| HemaCell | Jun 2026 | Series B | Co-investor |
| Geneus Technologies (Chengdu) Co., Ltd. | Sep 2021 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Xinhong Lim
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Wedo Venture Partners based?
Wedo Venture Partners is headquartered in Beijing, China.
When was Wedo Venture Partners founded?
Wedo Venture Partners was founded in 2016.
How many portfolio companies does Wedo Venture Partners have?
Wedo Venture Partners has 4 portfolio companies in Caplight's dataset.
What are some companies in Wedo Venture Partners's portfolio?
Portfolio companies visible on Caplight include Drug Farm, HemaCell, Geneus Technologies (Chengdu) Co., Ltd..
What was Wedo Venture Partners's most recent investment shown here?
Wedo Venture Partners's most recent investment in this portfolio sample was in Drug Farm in 2026.
What sectors does Wedo Venture Partners focus on?
Wedo Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Wedo Venture Partners focus on?
Stage focus information for Wedo Venture Partners is not publicly available.